Furthermore, ING2 can ablate the expression of the candidate proto-oncogene CIP2A, whereas transcription of matrix metalloproteinase 13 (MMP13) can be activated or repressed by ING2, depending on the cancer type analyzed, thereby regulating tumor invasiveness [7,50]. This evidence concerns the gene ING2 and cancer.